Stem Cell ApS
CVRCVR number44926180
Company financials
Key figures
Updated 29 Jun 2026
- Return on assets
- –
- Return on equity
- 37.8%
- Current ratio
- 2.4%
- Equity ratio
- 85.9%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -15,772 |
Finance income | 0 |
Tax expense | 0 |
Profit/loss for the year | 124,986 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 1 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 1,278 |
Current assets | 1,278 |
Non-current assets | 383,272 |
Total assets | 384,550 |
Equity | 330,300 |
Liabilities | 54,250 |
Current liabilities | 54,250 |
Working capital
| Reporting period | |
|---|---|
Trade payables | 6,250 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,000 |
Retained earnings | -15,772 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 383,272 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets formål er at drive investeringsvirksomhed, herunder ved at eje kapitalandele i datterselskaber, samt anden efter ledelsens skøn hermed tilknyttet virksomhed.
Development in activities and financial affairs
Selskabets resultatopgørelse for 2025 udviser et overskud på kr. 124.986, og selskabets balance pr. 31. december 2025 udviser en egenkapital på kr. 330.300.
Risks and material matters
Significant events after the reporting period
Der er efter regnskabsårets afslutning ikke indtruffet begivenheder, som væsentligt vil kunne påvirke selskabets finansielle stilling.
Commitments and security
Contingent liabilities
SambeskatningSelskabet er sambeskattet med moderselskabet MATIAS ANKJÆR INVEST ApS (Administrationsselskab) og hæfter solidarisk med øvrige sambeskattede selskaber for betaling af selskabsskat.
Create a free account to see up to 9 years of financial history
Create free account